Exhibit 99
NEWS FROM [HESKA LOGO]
1613 Prospect Parkway
Fort Collins, Colorado 80525
(t) 970-493-7272
(f) 970-484-9505
www.heska.com
FOR IMMEDIATE RELEASE
At Heska Corporation: At PondelWilkinson MS&L:
Robert Grieve, Chairman and CEO (Investor Relations)
(970) 493-7272, Ext. 4155 Rob Whetstone/Robert Jaffe
(310) 207-9300
HESKA CORPORATION ANNOUNCES MANAGEMENT CHANGES
Company Names New Chief Financial Officer
===============================================================================
FORT COLLINS, CO, May 7, 2002 -- Heska Corporation (Nasdaq: HSKA), a company
focused on innovative products for the companion animal healthcare market,
announced today that Jason Napolitano has been appointed Chief Financial
Officer, succeeding Ron Hendrick who has retired from the company.
"Jason has been a trusted outside adviser to Heska for many years, providing
strategic business judgement and sound financial guidance. We look forward to
benefiting from his analytical skills and full-time focus applied to more
aspects of our daily business as we continue our progress toward profitability,"
Chairman and Chief Executive Officer Robert Grieve said.
Napolitano joins Heska with a broad background in investment banking and
financial consulting expertise. He was a Director in the Mergers & Acquisitions
department of Credit Suisse First Boston, a firm he spent over 10 years with and
where his previous experience included four years of health care investment
banking. His responsibilities at Heska will include finance, investor relations
and corporate development.
Exhibit 99
"We also appreciate the commitment over the years of Ron Hendrick, Jason's
predecessor, in helping Heska divest certain businesses, raise capital and cut
costs, all with the goal of putting the company on a more sound financial
footing," Grieve said.
The company also announced that Jim Fuller, president and chief operating
officer, has informed the company that he intends to retire in June 2002. His
responsibilities will be assumed by Robert Grieve.
"Jim has been invaluable in developing and building the commercial aspects of
our business," said Grieve. "During his tenure, our companion animal healthcare
business grew substantially, as Jim was instrumental in helping to position
Heska as a true leader in our industry."
ABOUT HESKA CORPORATION
- -----------------------
Heska (Nasdaq: HSKA) develops and markets innovative products for the large and
growing companion animal health market. Veterinarians in the United States and
Europe count on Heska for state-of-the-art pharmaceuticals, vaccines and
diagnostic products for the testing and treatment of thousands of cats and dogs
each year, as well as for diagnostic and patient monitoring instrumentation and
supplies. Heska's Diamond Animal Health subsidiary operates a USDA- and FDA-
licensed facility, which manufactures vaccines and pharmaceutical products. For
additional information on Heska and its products, visit the company's web site
at www.heska.com.
FORWARD LOOKING STATEMENTS
This press release contains express or implied forward-looking information about
Heska's management changes and progress towards profitability that are forward-
looking statements within the meaning of the "safe harbor" provisions of the
Private Securities Litigation Reform Act of 1995. Such forward-looking
statements are subject to risks and uncertainties that may cause actual results
to be materially different from any future results expressed or implied by such
forward-looking statements, including failure of a successful management
transition; quality of management; competition; uncertainties regarding our
ability to raise sufficient capital or borrow sufficient cash to fund future
operations as needed; changes in business strategy or development plans;
inability to manufacture, market, sell or distribute products at currently
projected costs and the risks set forth in Heska's filings and future filings
with the Securities and Exchange Commission, including those set forth in
Heska's Annual Report on Form 10-K for the year ended December 31, 2001. These
forward-looking statements speak only as of the date hereof and Heska disclaims
any intent or obligation to update, revise or amend these forward-looking
statements to reflect changes in Heska's expectations or future events.
# # #
-2-